Page last updated: 2024-12-07

n(4)-methylcytosine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

n(4)-methylcytosine (4mC) is a modified base found in DNA, primarily in bacteria and some eukaryotes. It is formed by the methylation of cytosine at the N4 position. The formation of 4mC is catalyzed by DNA methyltransferases, and it plays a role in gene regulation and other cellular processes. 4mC is not as common in eukaryotic DNA as 5-methylcytosine (5mC), but it has been implicated in various biological functions. It is found in specific genomic regions, suggesting a potential role in gene expression regulation. Researchers are studying 4mC to understand its role in epigenetic regulation, DNA repair, and the development of cancer. Furthermore, understanding the functions of 4mC could have implications in developing novel therapeutic strategies.'

N(4)-methylcytosine : A pyrimidone that is cytosine bearing an N(4)-methyl substituent. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID122004
CHEBI ID21839
SCHEMBL ID19930
SCHEMBL ID13030167
MeSH IDM0117166

Synonyms (30)

Synonym
4n-methylcytosine
6220-47-9
6-(methylamino)-1h-pyrimidin-2-one
4-(methylamino)-2(1h)-pyrimidinone
4-METHYLAMINO-1H-PYRIMIDIN-2-ONE ,
n4-methylcytosine
CHEBI:21839
n(4)-methylcytosine
4-(methylamino)pyrimidin-2(1h)-one
4-(methylamino)pyrimidin-2-ol
2(1h)-pyrimidinone, 4-(methylamino)-
4-methylaminocytosine
AKOS006330221
4-(methylamino)-2-pyrimidinol
FT-0687997
AB60627
6-(methylamino)pyrimidin-2(1h)-one
SCHEMBL19930
SCHEMBL13030167
PJKKQFAEFWCNAQ-UHFFFAOYSA-N
4-(methylamino)-2(1h)-pyrimidinone #
J-513768
6-(methylamino)-2(1h)-pyrimidinone
Q15632688
AMY16237
A935251
noname_3509
DTXSID40902933
F81507
CS-0366447
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
aminopyrimidineA member of the class of pyrimidines that is pyrimidine substituted by at least one amino group and its derivatives.
pyrimidoneA pyrimidine carrying one or more oxo substituents.
methylcytosine
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (32)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (37.50)18.7374
1990's6 (18.75)18.2507
2000's4 (12.50)29.6817
2010's6 (18.75)24.3611
2020's4 (12.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.45

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.45 (24.57)
Research Supply Index3.53 (2.92)
Research Growth Index4.98 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.45)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other33 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]